Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ospemifene for the treatment of menopausal vaginal dryness, a symptom of the genitourinary syndrome of menopause
David F. Archer, James A. Simon, David Portman, et al.
Expert Review of Endocrinology & Metabolism (2019) Vol. 14, Iss. 5, pp. 301-314
Open Access | Times Cited: 23

Showing 23 citing articles:

The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women
Haitham Hamoda, Nick Panay, Hugo Pedder, et al.
Post Reproductive Health (2020) Vol. 26, Iss. 4, pp. 181-209
Open Access | Times Cited: 136
Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society
Ιrene Lambrinoudaki, Eleni Armeni, Dimitrios G. Goulis, et al.
Maturitas (2022) Vol. 163, pp. 1-14
Closed Access | Times Cited: 59
Androgens, oestrogens and endometrium: a fine balance between perfection and pathology
Douglas A Gibson, Ioannis Simitsidellis, Frances Collins, et al.
Journal of Endocrinology (2020) Vol. 246, Iss. 3, pp. R75-R93
Open Access | Times Cited: 57
Medical Treatment of Female Sexual Dysfunction
Rossella E. Nappi, Lara Tiranini, Ellis Martini, et al.
Urologic Clinics of North America (2022) Vol. 49, Iss. 2, pp. 299-307
Closed Access | Times Cited: 28
Effect of Vitamin D Supplement on Vulvovaginal Atrophy of the Menopause
Thawinee Kamronrithisorn, Jittima Manonai, Sakda Arj-Ong Vallibhakara, et al.
Nutrients (2020) Vol. 12, Iss. 9, pp. 2876-2876
Open Access | Times Cited: 21
Menopause and female sexual dysfunctions
Laura Cucinella, Ellis Martini, Lara Tiranini, et al.
Minerva Obstetrics and Gynecology (2022) Vol. 74, Iss. 3
Closed Access | Times Cited: 10
Safety and efficacy of fractional CO2 laser treatment to the vestibule: a randomized, double-blind, sham-controlled, prospective 3-site clinical study in women with vestibular pain
S Goldstein, Irwin Goldstein, Noel N. Kim, et al.
The Journal of Sexual Medicine (2023) Vol. 20, Iss. 6, pp. 800-812
Closed Access | Times Cited: 6
Impact of vulvovaginal atrophy therapies on postmenopausal women's quality of life in the CRETA study measured by the Cervantes scale
Santiago Palacios, Rafael Sánchez-Borrego, Beatriz Suárez Álvarez, et al.
Maturitas (2023) Vol. 172, pp. 46-51
Open Access | Times Cited: 6
The role of hormone therapy in urogenital health after menopause
Rossella E. Nappi, Laura Cucinella, Ellis Martini, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2021) Vol. 35, Iss. 6, pp. 101595-101595
Closed Access | Times Cited: 13
Reproductive late effects after hematopoietic stem cell transplant in pediatric, adolescent, and young adult cancer survivors
Leslie Appiah, Molly B. Moravek, Holly Hoefgen, et al.
Pediatric Blood & Cancer (2023) Vol. 70, Iss. S5
Open Access | Times Cited: 5
Rate, burden, and treatment of sexual dysfunction in multiple sclerosis: The case for exercise training as a new treatment approach
Dena Sadeghi Bahmani, Robert W. Motl
Multiple Sclerosis and Related Disorders (2021) Vol. 51, pp. 102878-102878
Closed Access | Times Cited: 12
A real-world disproportionality analysis of ospemifene: data mining of the public version of FDA adverse event reporting system
Haixiao Wen, Chong Lu, Meng Zhang, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 11, pp. 1133-1142
Closed Access | Times Cited: 4
Ospemifene and vulvovaginal atrophy: an update of the clinical profile for post-menopausal women
Costantino Di Carlo, Angelo Cagnacci, Filippo Murina, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 11, pp. 1541-1554
Open Access | Times Cited: 1
Genitourinary syndrome of menopause: Should we treat symptoms or signs?
Laura Cucinella, Ellis Martini, Lara Tiranini, et al.
Current Opinion in Endocrine and Metabolic Research (2022) Vol. 26, pp. 100386-100386
Closed Access | Times Cited: 5
Sexuality, pelvic floor/vaginal health and contraception at menopause
Rossella E. Nappi, Laura Cucinella
Best Practice & Research Clinical Obstetrics & Gynaecology (2021) Vol. 81, pp. 85-97
Closed Access | Times Cited: 6
Vestibular tissue changes following administration of intravaginal prasterone: a vulvoscopic open-label pilot study in menopausal women with dyspareunia
S Goldstein, Irwin Goldstein, Noel N. Kim
Sexual Medicine (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 2
Modern approaches to the management of menopause
Н. В. Артымук, O. A. Tachkova, T.Yu. Marochko
GYNECOLOGY (2021) Vol. 23, Iss. 2, pp. 137-143
Closed Access | Times Cited: 4
Modern Possibilities of Correction of Sexual Dysfunction in Women with Neurological Diseases. A Review
N. A. Mirkhamidova, Adiba A. Usmankhodjaeva
Medicina (2024) Vol. 12, Iss. 1, pp. 88-108
Open Access
Hormone Replacement Therapy (And Other Options to Treat Menopausal Symptoms)
Ιrene Lambrinoudaki, Eleni Armeni, Elina Silionga
(2024), pp. 153-167
Closed Access
Sexual function analysis and clitoral vascularization in postmenopausal women with genitourinary syndrome treated with ospemifene
Michele Carlo Schiavi, Pietro Cignini, Marzio Angelo Zullo, et al.
Minerva Obstetrics and Gynecology (2021) Vol. 75, Iss. 2
Closed Access | Times Cited: 2

Silvia Maffei, Angela Papa, Pietro Di Cecco, et al.
(2020) Vol. 7, Iss. 4
Open Access
Menopause Management
Makeba Williams
Springer eBooks (2021), pp. 1-14
Closed Access

Silvia Maffei, Angela Papa, Pietro Di Cecco, et al.
(2021) Vol. 8, Iss. 3
Open Access
Page 1

Scroll to top